Pulse Therapeutics’ $1.3 million investors

FTL Capital and Cultivation Capital chipped in last month to fund Pulse Therapeutics, the medical device company based out of the Downtown T-REx co-working space.

Pulse raised $1.3 million from three investors, including FTL and Cultivation. The third investor has not been named.

Pulse was founded in 2009 by Francis Creighton and Rogers Ritter, and is developing a magnet-based technology to dissolve blood clots.

St. Louis Business Journal